Skip to main content
Have a personal or library account? Click to login
Clinical and Mutagenic Spectrum of Highly Pathogenic Avian Influenza A(H5N1) Clade 2.3.4.4B: A Narrative Review Cover

Clinical and Mutagenic Spectrum of Highly Pathogenic Avian Influenza A(H5N1) Clade 2.3.4.4B: A Narrative Review

By:  and    
Open Access
|Sep 2026

References

  1. World Health Organization. Assessment of risk associated with recent influenza A(H5N1) clade 2.3.4.4b viruses [Internet]. Geneva: World Health Organization; 2022 Dec 21 [cited 2025 Dec 10]. Available from: https://cdn.who.int/media/docs/default-source/influenza/avian-and-other-zoonotic-influenza/h5-risk-assessment-dec-2022.pdf?sfvrsn=a496333a_1&download=true
  2. Agüero M, Monne I, Sánchez A, et al. Highly pathogenic avian influenzaA(H5N1) virus infection in farmed minks, Spain, October 2022. Euro Surveill. 2023;28. doi:10.2807/1560-7917. ES.2023.28.3.2300001
  3. Rijks JM, Hesselink H, Lollinga P, et al. Highly Pathogenic Avian Influenza A(H5N1) Virus in Wild Red Foxes, the Netherlands, 2021. Emerg Infect Dis. 2021;27:2960-2.
  4. Lindh E, Lounela H, Ikonen N, et al. Highly pathogenic avian influenza A(H5N1) virus infection on multiple fur farms in the South and Central Ostrobothnia regions of Finland, July 2023. Euro Surveill. 2023;28(31):2300400.
  5. Banyard AC, Bennison A, Byrne AMP, et al. Detection and spread of highly pathogenic avian influenza virus H5N1 in the Antarctic Region. Nat Commun. 2024;15(1):7433. doi:10.1038/s41467-024-51490-8
  6. Lin S, Chen J, Li K, et al. Evolutionary dynamics and comparative pathogenicity of clade 2.3.4.4b H5 subtype avian influenza viruses, China, 2021-2022. Virol Sin. 2024;39:358-368.
  7. Jahid MJ, Nolting JM. Dynamics of a panzootic: genomic insights, host range, and epidemiology of the highly pathogenic avian influenza A(H5N1) clade 2.3.4.4b in the United States. Viruses. 2025;17:312. doi:10.3390/v17030312
  8. Graziosi G, Lupini C, Catelli E, Carnaccini S. Highly pathogenic avian influenza (HPAI) H5 clade 2.3.4.4b virus infection in birds and mammals. Animals (Basel). 2024;14:1372.
  9. Rather MA, Hassan A, Aman M, et al. Molecular and ecological determinants of mammalian adaptability in avian influenza virus. Infection. 2025. doi:10.1007/s15010-025-02529-5
  10. Briand FX, Souchaud F, Pierre I, et al. Highly pathogenic avian influenza A(H5N1) clade 2.3.4.4b virus in domestic cat, France, 2022. Emerg Infect Dis. 2023;29(8):1696-1698. doi:10.3201/eid2908.230188
  11. Tumpey TM, Maines TR, Van Hoeven LN, et al. A two-amino acid change in the hemagglutinin of the 1918 influenza virus abolishes transmission. Science. 2007;315:655-659.
  12. Lin TH, Zhu X, Wang S, et al. A single mutation in bovine influenza H5N1 hemagglutinin switches specificity to human receptors. Science. 2024;386:1128-1134. doi:10.1126/science.adt0180.
  13. Paulson JC, de Vries RP. H5N1 receptor specificity as a factor in pandemic risk. Virus Res. 2013;178:99-113.
  14. de Vries RP, Peng W, Grant OC, et al. Three mutations switch H7N9 influenza to human-type receptor specificity. PLoS Pathog. 2017;13:e1006390.
  15. Tanner WD, Toth DJ, Gundlapalli AV. The pandemic potential of avian influenza A(H7N9) virus: a review. Epidemiol Infect. 2015; 143(16) :3359-3374. doi:10.1017/S0950268815001570
  16. Eggink D, Spronken M, van der Woude R, et al. Phenotypic effects of substitutions within the receptor binding site of highly pathogenic avian influenza H5N1 virus observed during human infection. J Virol. 2020;94(13):e00195-20. doi:10.1128/JVI.00195-20
  17. European Centre for Disease Prevention and Control. Current case definition fer zoonotic influenza in humans [Internet]. Stockholm: ECDC; [cited 2025 Dec 10]. Available from: https://www.ecdc.europa.eu/en/infectious-disease-topics/avian-influenza/disease-infbrmation-avian-influenza/current-case
  18. World Health Organization. WHO case definition for human infections with avian influenza A(H5) virus [Internet], Geneva: World Health Organization; [date unknown] [cited 2025 Dec 10], Available from: https://www.who.int/teams/global-influenza-programme/avian-influenza/case-definitions
  19. Drehoff CC. White EB. Frutos AM et al. Cluster of influenza A(H5) cases associated with poultry exposure at two facilities - Colorado, July 2024. MMWR Morb Mortal Wkly Rep. 2024;73(34):734-739. doi:10.15585/mmwr.mm7334a1
  20. Uyeki TM, Milton S, Abdul Hamid C, et al. Highly pathogenic avian influenza A(H5N1) virus infection in a dairy farm worker. N Engl J Med. 2024;390:2028-9. doi:10.1056/ NEJMc2405371
  21. Castillo A, Fasce R, Parra B, et al. The first case of human infection with H5N1 avian Influenza A virus in Chile. J Travel Med. 2023;30(5):taad083. doi:10.1093/jtm/taad083
  22. Pardo-Roa C, Nelson MI, Ariyama N, et al. Cross-species and mammal-to-mammal transmission of clade 2.3.4.4b highly pathogenic avian influenza A/H5N1 with PB2 adaptations. Nat Commun. 2025;16(1):2232. doi:10.1038/s41467-025-57338-z
  23. Ministerio de Salud, Gobierno de Chile. MINSAL informa primer caso humano de gripe aviar en Chile [Internet]. Santiago: Ministerio de Salud, Gobierno de Chile; 2023 [cited 2025 Dec 10]. Available from: https://www.paho.org/sites/default/files/2024-12/2024-dic-3-phe-alerta-influenzaaviar-esp-final1_2.pdf
  24. Zhang Y, Wu J, Lin Q, et al. Infection Tracing and Virus Genomic Analysis of Two Cases of Human Infection with Avian Influenza A(H5N6) - Fujian Province, China, April-May 2024. China CDC Wkly. 2025;7(3):107-112. doi:10.46234/ccdcw2024.274
  25. Yu H, Jin K, Ding S, et al. Severe Avian Influenza A H5N1 Clade 2.3.4.4b Virus Infection in a Human with Continuation of SARS-CoV-2 Viral RNAs. Transbound Emerg Dis. 2024;2024:8819622. doi:10.1155/2024/8819622
  26. Zhang L, Liu K, Su Q, et al. Clinical features of the first critical case of acute encephalitis caused by the avian influenza A (H5N6) virus. Emerg Microbes Infect. 2022;11(1):2437–2446. doi:10.1080/22221751.2022.2122584
  27. Huang Z, Zhang R, Yao D, et al. Avian influenza A(H5N6) virus detected during live-poultry market surveillance linked to a human infection in Changsha, China, from 2020 to 2023. Arch Virol. 2025;170(5):96. doi:10.1007/s00705-025-06280-y
  28. Mellis AM, Coyle J, Marshall KE, et al. Serologic Evidence of Recent Infection with Highly Pathogenic Avian Influenza A(H5) Virus Among Dairy Workers – Michigan and Colorado, June-August 2024. MMWR Morb Mortal Wkly Rep. 2024;73(44):1004-1009. doi:10.15585/mmwr.mm7344a3
  29. Zhu S, Harriman K, Liu C, et al. Human Cases of Highly Pathogenic Avian Influenza A(H5N1) – California, September-December 2024. MMWR Morb Mortal Wkly Rep. 2025;74(8):127-133. doi:10.15585/mmwr.mm7408a1
  30. Garg S, Reinhart K, Couture A, et al. Highly pathogenic avian influenza A(H5N1) virus infections in humans. N Engl J Med. 2025;392:843–54. doi:10.1056/NEJMoa2414610
  31. Siddiqui E, Khalid M, Khan MS, et al. The Missouri H5 flu case: a call for strengthening public health preparedness. Ann Med Surg. 2025;87(1):33-35. doi:10.1097/ MS9.0000000000002866
  32. Oliverl, Roberts J, Brown CS, etal.Acaseof avian influenzaA(H5N 1) in England, January 2022. Euro Surveill. 2022;27(5):2200061. doi:10.2807/1560-7917.ES.2022.27.5.2200061
  33. Zeng Q, Wang J, Zhang X, et al. Successful combinatorial therapy of sirolimus and neuraminidase inhibitors in a patient with highly pathogenic avian influenza A (H5N6) vims: a case report. Ann Transl Med. 2022;10(5):265. doi:10.21037/atm-22-704
  34. Yu JL, Hou S, Feng YT, et al. Emergence of a young case infected with avian influenza A (H5N6) in Anhui Province, East China during the COVID-19 pandemic. J Med Virol. 2021 ;93(10):5998-6007. doi:10.1002/jmv.27179
  35. He J, Duan J. First human case of avian influenza A (H5N6) in Yunnan province, China. SAGE Open Med Case Rep. 2015;3:2050313X15596484. doi: 10.1177/2050313X15596484
  36. Wei SH, Yang JR, Wu HS, et al. Human infection with avian influenza A H6N1 virus: an epidemiological analysis. Lancet Respir Med. 2013;1(10):771-778. doi:10.1016/S2213-2600(13)70221-2
  37. Zhang J. H7N9 avian influenza with first manifestation of occipital neuralgia: A case report. World J Clin Cases. 2023;11(2) :434–440. doi:10.12998/wjcc.v11.i2.434
  38. He H, Wang H, Li X, et al. Successful management of refractory respiratory failure caused by avian influenza H7N9 and secondary organizing pneumonia: a case report and literature review. BMC Infect Dis. 2019;19(1):671. doi:10.1186/s12879-019-4306-7
  39. Luo H, Wang S, Yuan T, et al. Clinical characteristics from co-infection with avian influenza A H7N9 and Mycoplasma pneumoniae: a case report. J Med Case Rep. 2018;12(1):77. doi:10.1186/s13256-018-1583-5
  40. Xie H, Zhou ZG, Jin W, et al. Ventilator management for acute respiratory distress syndrome associated with avian influenza A (H7N9) virus infection: A case series. World J Emerg Med. 2018;9(2):118-124. doi:10.5847/ wjem.j.1920-8642.2018.02.006
  41. Zhang ZH, Meng LS, Kong DH, et al. A Suspected Person-to-person Transmission of Avian Influenza A (H7N9) Case in Ward. Chin Med J. 2017;130(10):1255-1256. doi:10.4103/0366-6999.205849
  42. Zhao Z, Luo S, Gao Y, et al. A case report of human infection with avian influenza H10N3 with a complex respiratory disease history. BMC Infect Dis. 2024;24(1):918. doi:10.1186/ s12879-024-09830-y
  43. World Health Organization. Cumulative number of confirmed human cases for avian influenza A(H5N1) reported to WHO, 2003-2024 [Internet]. Geneva: World Health Organization; 2024 Dec 12 [cited 2025 Dec 10]. Available from: https://cdn.who.int/media/docs/default-source/2021-dha-docs/cumulative-number-of-confirmed-human-cases-for-avian-influenza-a(h5n1)-reported-to-who--2003-2024.pdf
  44. Li F, Sun Z, Tao M, et al. Epidemiological characterization of human infection with H5N6 avian influenza. Front Public Health. 2024;12:1398365. doi:10.3389/ fpubh.2024.1398365
  45. Purcell R, Giles ML, Crawford NW, et al. Systematic Review of Avian Influenza Virus Infection and Outcomes during Pregnancy. Emerg Infect Dis. 2025;31(1):50-56. doi:10.3201/ e id3101.241343
  46. Sandhu S, Ferrante C, MacCosham A, et al. Epidemiological characteristics of human infections with avian influenza A(H5N6) virus, China and Laos: A multiple case descriptive analysis, February 2014-June 2023. Can Commun Dis Rep. 2024;50(1-2):77-85. doi:10.14745/ccdr.v50i12a09
  47. Pan H, Zhang X, Hu J, et al. A case report of avian influenza H7N9 killing a young doctor in Shanghai, China. BMC Infect Dis. 2015;15:237. doi:10.1186/s12879-015-0970-4
  48. Wang D, Tang G, Huang Y, et al. A returning migrant worker with avian influenza A (H7N9) vims infection in Guizhou, China: a case report. J Med Case Rep. 2015;9:109. doi:10.1186/ s13256-015-0580-1
  49. Titorenkov PT, Encheva MD, Gotseva AL. Respiratory infections in the XXI century: Challenges and changes. World J Adv Res Rev. 2024;23(3):1900-1906. doi:10.30574/ wjarr.2024.23.3.2730
  50. Gotseva A Complications of Influenza. Medinfo, 2024;24(8):8-11
  51. Krammer F, Schultz-Cherry S. We need to keep an eye on avian influenza. Nat Rev Immunol. 2023;23:267–268.
DOI: https://doi.org/10.2478/amb-2026-0076 | Journal eISSN: 2719-5384 (formerly 0324-1750) | Journal ISSN: 0324-1750
Language: English
Page range: 75 - 82
Submitted on: Dec 13, 2025
Accepted on: Jan 26, 2026
Published on: Sep 14, 2026
Published by: Medical University - Sofia
In partnership with: Paradigm Publishing Services

© 2026 P. Velikov, T. Valkov, published by Medical University - Sofia
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.